Across the SUSTAIN program, the primary and confirmatory secondary endpoints for most trials were change from baseline in HbA 1c and body weight, respectively, to the end of treatment (30, 40, 52, or 56 weeks) (1625)
Glutamine may help reduce symptoms by improving gut lining integrity, balancing the gut microbiota, and modulating inflammation
In the present study, we are the first to verify that NAC intervention reverses endocrine-metabolic parameters and ovarian pathological phenotypes in LE-induced PCOS mouse models
About a dozen states currently cover GLP-1 medications for obesity, while others exclude them or require special authorization
53,54 Two recent trials further support a possible role for GLP-1 analogues in dementia prevention
These may indicate complications such as pancreatitis, gallbladder disease, or severe dehydration requiring intervention